Literature DB >> 1397003

Effects of systemic morphine on diffuse noxious inhibitory controls: role of the periaqueductal grey.

D Bouhassira1, L Villanueva, D Le Bars.   

Abstract

The effects of systemic morphine (1 mg/kg i.v.) on diffuse noxious inhibitory controls (DNIC) were studied in both sham-operated animals and those with quinolinic acid-induced lesions of the periaqueductal grey (PAG). DNIC acting on convergent neurones in the dorsal horn of the spinal cord were similar in the sham-operated and lesioned animals. However, following morphine injection, DNIC were blocked in the sham-operated but not in the PAG-lesioned animals. It is concluded that, although the PAG is not directly involved in the supraspinal loop subserving DNIC, it can modulate these controls. In addition, as naloxone reversed the effects of morphine in the control group but reduced DNIC in the PAG-lesioned animals, it is suggested that more than one opioidergic system is involved in DNIC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1397003     DOI: 10.1016/0014-2999(92)90355-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Neural signatures in patients with neuropathic pain.

Authors:  A L Green; S Wang; J F Stein; E A C Pereira; M L Kringelbach; X Liu; J-S Brittain; T Z Aziz
Journal:  Neurology       Date:  2009-02-10       Impact factor: 9.910

2.  Psychophysical testing of spatial and temporal dimensions of endogenous analgesia: conditioned pain modulation and offset analgesia.

Authors:  Liat Honigman; David Yarnitsky; Elliot Sprecher; Irit Weissman-Fogel
Journal:  Exp Brain Res       Date:  2013-05-28       Impact factor: 1.972

3.  Blockade of opioid receptors in the medullary reticularis nucleus dorsalis, but not the rostral ventromedial medulla, prevents analgesia produced by diffuse noxious inhibitory control in rats with muscle inflammation.

Authors:  Marcos A de Resende; Luis Felipe S Silva; Karina Sato; Lars Arendt-Nielsen; Kathleen A Sluka
Journal:  J Pain       Date:  2011-02-17       Impact factor: 5.820

4.  Cerebral and cerebrospinal processes underlying counterirritation analgesia.

Authors:  Mathieu Piché; Marianne Arsenault; Pierre Rainville
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

5.  Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls.

Authors:  C H Wilder-Smith; D Schindler; K Lovblad; S M Redmond; A Nirkko
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

6.  Dysfunctional pain inhibition in patients with chronic whiplash-associated disorders: an experimental study.

Authors:  Liesbeth Daenen; Jo Nijs; Nathalie Roussel; Kristien Wouters; Michel Van Loo; Patrick Cras
Journal:  Clin Rheumatol       Date:  2012-09-16       Impact factor: 2.980

7.  Studies of brain structures involved in diffuse noxious inhibitory controls in the rat: the rostral ventromedial medulla.

Authors:  D Bouhassira; Z Bing; D Le Bars
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

8.  Sex differences in the stability of conditioned pain modulation (CPM) among patients with chronic pain.

Authors:  Marc O Martel; Ajay D Wasan; Robert R Edwards
Journal:  Pain Med       Date:  2013-08-07       Impact factor: 3.750

Review 9.  Developments in Understanding Diffuse Noxious Inhibitory Controls: Pharmacological Evidence from Pre-Clinical Research.

Authors:  Mateusz Wojciech Kucharczyk; Diego Valiente; Kirsty Bannister
Journal:  J Pain Res       Date:  2021-04-20       Impact factor: 3.133

10.  Effects of Transcranial Direct Current Stimulation Block Remifentanil-Induced Hyperalgesia: A Randomized, Double-Blind Clinical Trial.

Authors:  Gilberto Braulio; Savio C Passos; Fabricio Leite; Andre Schwertner; Luciana C Stefani; Ana C S Palmer; Iraci L S Torres; Felipe Fregni; Wolnei Caumo
Journal:  Front Pharmacol       Date:  2018-02-19       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.